TY - JOUR
T1 - The chronic wound characterisation study and biobank
T2 - a study protocol for a prospective observational cohort investigation of bacterial community composition, inflammatory responses and wound-healing trajectories in non-healing wounds
AU - Iversen, Anne Kristine Servais
AU - Lichtenberg, Mads
AU - Fritz, Blaine Gabriel
AU - Díaz-Pinés Cort, Isabel
AU - Al-Zoubaidi, Dania Firas
AU - Gottlieb, Hans
AU - Kirketerp-Møller, Klaus
AU - Bjarnsholt, Thomas
AU - Jakobsen, Tim Holm
N1 - © Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
PY - 2024/10/17
Y1 - 2024/10/17
N2 - INTRODUCTION: Chronic wounds affect 1%-2% of the global population, with rising incidence due to ageing and lifestyle-related diseases. Bacterial biofilms, found in 80% of chronic wounds, and scattered single-cell bacteria may hinder healing. Microbes are believed to negatively impact healing by exacerbating inflammation and host immune response.METHODS AND ANALYSIS: The primary objective of the chronic wound characterisation (CWC) study is to investigate chronic wounds through a prospective observational cohort study exploring bacterial community composition, inflammatory responses and the influence of bacteria on wound-healing trajectories. The CWC study will be investigated through two cohorts: the predictive and in-depth.The predictive cohort includes patients with a chronic wound scheduled for mechanical debridement. The debrided material will be collected for dual RNA sequencing and 16s ribosomal RNA gene sequencing, as well as samples for microbial culturing and a photo to assess the wound. Clinical data is recorded, and healing and/or other clinical endpoints are established through medical records.The in-depth cohort includes and follows patients undergoing split-thickness skin grafting. Extensive sampling (ESwabs, biopsies, tape strips, debrided material and a sample of the skin graft) will be performed on surgery and patients will be seen at two follow-up visits. Samples will be analysed through culturing and next-generation sequencing methods. A biobank will be established comprising longitudinal clinical samples and clinical data.ETHICS AND DISSEMINATION: The study has been approved by the board of health ethics, Capital Region of Denmark, under protocol number H-20032214. The study findings will be disseminated through peer-reviewed publications and showcased at both national and international conferences and meetings within the domains of microbiology, wound healing and infection.
AB - INTRODUCTION: Chronic wounds affect 1%-2% of the global population, with rising incidence due to ageing and lifestyle-related diseases. Bacterial biofilms, found in 80% of chronic wounds, and scattered single-cell bacteria may hinder healing. Microbes are believed to negatively impact healing by exacerbating inflammation and host immune response.METHODS AND ANALYSIS: The primary objective of the chronic wound characterisation (CWC) study is to investigate chronic wounds through a prospective observational cohort study exploring bacterial community composition, inflammatory responses and the influence of bacteria on wound-healing trajectories. The CWC study will be investigated through two cohorts: the predictive and in-depth.The predictive cohort includes patients with a chronic wound scheduled for mechanical debridement. The debrided material will be collected for dual RNA sequencing and 16s ribosomal RNA gene sequencing, as well as samples for microbial culturing and a photo to assess the wound. Clinical data is recorded, and healing and/or other clinical endpoints are established through medical records.The in-depth cohort includes and follows patients undergoing split-thickness skin grafting. Extensive sampling (ESwabs, biopsies, tape strips, debrided material and a sample of the skin graft) will be performed on surgery and patients will be seen at two follow-up visits. Samples will be analysed through culturing and next-generation sequencing methods. A biobank will be established comprising longitudinal clinical samples and clinical data.ETHICS AND DISSEMINATION: The study has been approved by the board of health ethics, Capital Region of Denmark, under protocol number H-20032214. The study findings will be disseminated through peer-reviewed publications and showcased at both national and international conferences and meetings within the domains of microbiology, wound healing and infection.
KW - Humans
KW - Wound Healing
KW - Prospective Studies
KW - Biological Specimen Banks
KW - Chronic Disease
KW - Inflammation/microbiology
KW - Debridement/methods
KW - Microbiota
KW - Skin Transplantation
KW - Bacteria/genetics
KW - Biofilms
KW - Observational Studies as Topic
KW - RNA, Ribosomal, 16S/genetics
KW - Research Design
KW - Wounds and Injuries/microbiology
UR - http://www.scopus.com/inward/record.url?scp=85206820146&partnerID=8YFLogxK
U2 - 10.1136/bmjopen-2024-084081
DO - 10.1136/bmjopen-2024-084081
M3 - Journal article
C2 - 39419618
SN - 2044-6055
VL - 14
SP - e084081
JO - BMJ Open
JF - BMJ Open
IS - 10
M1 - e084081
ER -